Update
Iqvia quietly purchased UK-based NLP provider Linguamatics
Iqvia acquired UK-based Linguamatics in January 2019 as part of the company's commitment to deliver value from artificial intelligence and machine learning.
Archives for February 12, 2019
Mylan’s generic to cost 70% less then Advair
Mylan’s recently FDA-approved Advair Diskus generic to be offered at 70% cost reduction to its reference drug, and 67% less than GSK’s generic version.
Croatia-headquartered Optimapharm acquires Swiss CRO
Optimapharm aims to become a leading mid-sized CRO in Europe and recently acquired the Switzerland-headquartered company Denothex as part of this goal.
Medidata, Cognizant form strategic alliance to empower digital transformation
Medidata is working with Cognizant to develop a set of services that will provide pharma, biotech, CROs and others with the capabilities to “digitally transform” their research and commercialization.
Dr. Reddy’s facility struck by another Form 483
Dr. Reddy’s Bachupally manufacturing plant has received a second Form 483 from the US FDA in the past two years.
FDA secures supply chain with pilot program testing tech
US FDA initiates a pilot project testing innovations in an aim to inform the development of the tracking and verification systems going into effect with the DCSA in 2023.
Will advances in digital health be driven by a combination of Silicon Valley know-how and clinical trial expertise?
It will take a marriage between Silicon Valley and clinical trials expertise to drive innovation in the digital health space, which is being held back by uncertainty – and a reluctance that is keeping industry executives up at night.
Ligand and Genagon ink drug development agreement
Ligand Pharmaceuticals enters an agreement with Genagon to provide access to its drug development platform capable of producing fully human antibodies.